Inspire Medical Systems Inc
NYSE:INSP
Net Margin
Inspire Medical Systems Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
3.9B USD |
8%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
45.4B USD |
27%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
29B AUD |
52%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
11.4B USD |
39%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.4T JPY |
14%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
65.2B SEK |
27%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.7B USD |
3%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
265.7B INR | N/A | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
21.1B CNY |
3%
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
-4%
|
Inspire Medical Systems Inc
Glance View
Inspire Medical Systems Inc. emerged as a beacon of innovation in the medical technology landscape, carving a niche within the realm of obstructive sleep apnea (OSA) treatment. Founded with a vision to redefine the approach to sleep disorders, the company developed a breakthrough solution—a device that stimulates the hypoglossal nerve to maintain an open airway during sleep. This technology, known as Inspire therapy, represents a significant departure from traditional treatments like the cumbersome and often uncomfortable Continuous Positive Airway Pressure (CPAP) machines. By addressing the root cause of airway obstruction, Inspire provides an effective, less intrusive alternative, enhancing the overall quality of life for patients who struggle with conventional methods. Inspire Medical Systems makes money by marketing its implantable device primarily through a network of sleep centers and hospitals. The company operates in a business model that combines device sales with a supportive service infrastructure, ensuring that both healthcare providers and patients are well-acquainted with its innovative therapy. The revenue stream is fueled not only by the initial sales of the device but also through ongoing follow-ups and software updates necessary for optimal device functionality. By positioning itself at the intersection of customer care and cutting-edge technology, Inspire captures significant value in the growing OSA market, all while reinforcing its reputation as a leader in innovative medical solutions.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Inspire Medical Systems Inc's most recent financial statements, the company has Net Margin of 7.9%.
You don't have any saved screeners yet